Literature DB >> 22831765

Stases are associated with blood-brain barrier damage and a restricted activation of coagulation in SHRSP.

Holger Braun1, Celine Z Bueche, Cornelia Garz, Andreas Oldag, Hans-Jochen Heinze, Michael Goertler, Klaus G Reymann, Stefanie Schreiber.   

Abstract

Cerebral small vessel disease (CSVD) is a chronically proceeding pathology of small brain vessels associated with white matter lesions, lacunar infarcts, brain atrophy and microbleeds. CSVD leads to slowly increasing cognitive and functional deficits but may also cause stroke-like symptoms, if vessels in critical brain areas are affected. Spontaneously hypertensive stroke-prone rats (SHRSP) exhibit several vascular risk factors, develop infarcts and hemorrhages and therefore represent a relevant model for the study of CSVD. Using this animal model, we recently demonstrated that intravasal accumulations of erythrocytes, we interpreted as stases, stand at the beginning of a pathological vascular cascade. After stases microbleeds occur, which are followed by reactive microthromboses. Bleeds and thromboses finally cause hemorrhagic infarcts. Immunohistochemical stainings show, that plasma proteins like IgG are deposited in the walls of vessels affected by stases. Further, we found small clots and thread-shaped aggregations of thrombocytes as well as thread-shaped structures of von Willebrand-Factor within stases. Thus, we conclude that blood-brain barrier damages occur in the neighborhood of stases and stases seem to be associated with a restricted activation of blood coagulation without formation of obstructive thromboses. Finally, we demonstrate that small vessel damage rarely appears in the cerebellum. Even animals with multiple cerebral infarcts may be free of any cerebellar vascular pathology.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22831765     DOI: 10.1016/j.jns.2012.06.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  A mouse model of subcortical vascular dementia reflecting degeneration of cerebral white matter and microcirculation.

Authors:  Eek-Sung Lee; Jin-Hui Yoon; Jiye Choi; Faris R Andika; Taekwan Lee; Yong Jeong
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-20       Impact factor: 6.200

2.  Gliovascular disruption and cognitive deficits in a mouse model with features of small vessel disease.

Authors:  Philip R Holland; James L Searcy; Natalia Salvadores; Gillian Scullion; Guiquan Chen; Greig Lawson; Fiona Scott; Mark E Bastin; Masafumi Ihara; Rajesh Kalaria; Emma R Wood; Colin Smith; Joanna M Wardlaw; Karen Horsburgh
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

3.  Early microvascular dysfunction in cerebral small vessel disease is not detectable on 3.0 Tesla magnetic resonance imaging: a longitudinal study in spontaneously hypertensive stroke-prone rats.

Authors:  Stine Mencl; Cornelia Garz; Solveig Niklass; Holger Braun; Eva Göb; György Homola; Hans-Jochen Heinze; Klaus G Reymann; Christoph Kleinschnitz; Stefanie Schreiber
Journal:  Exp Transl Stroke Med       Date:  2013-06-25

4.  Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model.

Authors:  Stefanie Schreiber; Celine Zoe Bueche; Cornelia Garz; Holger Braun
Journal:  Exp Transl Stroke Med       Date:  2013-03-14

5.  NAC changes the course of cerebral small vessel disease in SHRSP and reveals new insights for the meaning of stases - a randomized controlled study.

Authors:  Celine Zoe Bueche; Cornelia Garz; Siegfried Kropf; Daniel Bittner; Wenjie Li; Michael Goertler; Hans-Jochen Heinze; Klaus Reymann; Holger Braun; Stefanie Schreiber
Journal:  Exp Transl Stroke Med       Date:  2013-04-15

6.  Intravital imaging in spontaneously hypertensive stroke-prone rats-a pilot study.

Authors:  Solveig Niklass; Stoyan Stoyanov; Cornelia Garz; Celine Z Bueche; Stine Mencl; Klaus Reymann; Hans-Jochen Heinze; Roxana O Carare; Christoph Kleinschnitz; Stefanie Schreiber
Journal:  Exp Transl Stroke Med       Date:  2014-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.